Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Legend Biotech Corporation - American Depositary Shares | 9LB | 12. jui 2024 | 42.20 | +1.93 |
Mabion S.A. | 272 | 12. jui 2024 | 3.96 | +0.13 |
Medesis Pharma S.A. | 76D | 12. jui 2024 | 0.91 | +3.41 |
Medmira Inc | 47M | 12. jui 2024 | 0.05 | 0.00 |
Memphasys Limited | IG7 | 12. jui 2024 | 0.00 | 0.00 |
Mesoblast Ltd | LWB | 12. jui 2024 | 0.63 | -5.97 |
Nanocarrier Co Ltd | 3NQ | 12. jui 2024 | 0.72 | 0.00 |
NetScientific plc | NTK1 | 12. jui 2024 | 0.72 | -0.68 |
Newron Pharmaceuticals Spa. | NP5 | 12. jui 2024 | 10.38 | +3.39 |
Nuformix plc | 1RT | 12. jui 2024 | 0.00 | 0.00 |
Ocumension Therapeutics | 5DG | 12. jui 2024 | 0.77 | 0.00 |
Oncimmune Holdings plc | OCY | 12. jui 2024 | 0.13 | -2.29 |
Oncoarendi Therapeutics SA | 1B1 | 12. jui 2024 | 3.19 | -2.89 |
Oncotherpapy Science Inc | 30O | 12. jui 2024 | 0.13 | +10.62 |
Open Orphan plc | CRO | 12. jui 2024 | 0.31 | -0.65 |
Opthea Limited | UKJ | 12. jui 2024 | 0.27 | 0.00 |
OptiBiotix Health plc | OB3 | 12. jui 2024 | 0.19 | -3.08 |
Oric Pharmaceuticals, Inc. | 4TZ | 12. jui 2024 | 7.35 | -3.92 |
Oxford BioDynamics plc | LMQ | 12. jui 2024 | 0.05 | -1.98 |
Oxford Biomedica | OXOA | 12. jui 2024 | 3.70 | -0.54 |
Pharmaron Beijing Co Ltd | 17Q1 | 12. jui 2024 | 1.14 | +6.54 |
Pharmaust Ltd. | ECQ | 12. jui 2024 | 0.14 | +16.24 |
Philogen S.p.a. | 78Q | 12. jui 2024 | 21.70 | -2.69 |
Physiomics | RVW1 | 12. jui 2024 | 0.01 | -5.00 |
Polynovo Limited | MFJ | 12. jui 2024 | 1.36 | +2.26 |
Poseida Therapeutics, Inc. | 2RZ | 12. jui 2024 | 2.51 | +3.37 |
Pure Biologics S A | PQB | 12. jui 2024 | 1.25 | -1.11 |
PureTech Health Plc | 0VQ | 12. jui 2024 | 2.62 | 0.00 |
Quantum Genomics | 2QG | 12. jui 2024 | 0.10 | -7.28 |
RECCE PHARMACEUTICALS Ordinary Fully Paid (Australia) | R9Q | 12. jui 2024 | 0.31 | +3.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.